November 16, 2012 – The U.S. Food and Drug Administration (FDA) has granted market clearance for the Avinger Inc. Ocelot ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
November 16, 2012
November 15, 2012 — The U.S. Food and Drug Administration (FDA) granted market clearance for Cook Medical’s Zilver PTX ...
November 15, 2012
Results from the POSEIDON Trial were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2012. Data showed a ...
November 09, 2012Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026
The PC Trial data presented at TCT 2012 looked at transcather PFO closure vs. medical therapy in preventing cryptogenic ...
November 09, 2012
November 9, 2012 — Svelte Medical Systems announced it received conditional approval from the U.S. Food and Drug ...
November 09, 2012Use of Rosuvastatin Prior to Angioplasty Does Not Influence Troponin I Release Following Angioplasty
November 9, 2012 — A study found that the use of rosuvastatin prior to angioplasty did not influence the levels of ...
November 09, 2012Sponsored Content
Blog | Contrast Media Injectors
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
August 22, 2023
November 8, 2012 — A clinical trial indicates that using an investigational medical device to close a PFO, or “hole in ...
November 08, 2012
November 8, 2012 — A hydration regimen tailored to the patient’s fluid status was effective in reducing damage to ...
November 08, 2012
November 8, 2012 — A U.S. Food and Drug Administration (FDA) advisory committee is meeting Dec. 5 to discuss how to ...
November 08, 2012Sponsored Content
Blog | Enterprise Imaging
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
August 10, 2023
November 8, 2012 — Boston Scientific Corp. is extending its reach into the renal denervation market by signing a ...
November 08, 2012
The results of the FAME II Trial were presented at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) meeting. The ...
November 07, 2012November 7, 2012 — Athera Biotechnologies AB announced that results from a new study were presented at the Pacific ...
November 07, 2012Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
November 6, 2012 — A study has found several benefits in using the radial artery in the arm as the entry point for ...
November 06, 2012
Feature | By Dave Fornell
Hospitals constantly try to predict what the future holds when planning new facilities and equipment purchases that will ...
November 06, 2012
November 6, 2012 — Vascular Solutions launched the R-Band radial hemostasis compression device in the United States ...
November 06, 2012